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Rigidity of the cell membrane is due to the presence of cholesterol, which 
makes it an vital component of the membrane. It also serves as precursor for steroids and 
bile acids. Absorption of biliary and dietary cholesterol in the. gut is an important source 
of cholesterol in humans. Despite the fact that cholesterol is an essential constituent in the 
system, excess blood cholesterol has been implicated as a primary cause of atherosclerosis, 
which in tum leads to cardiovascular disease and coronary heart disease (CHD). In a 
healthy man, an intricate balance is maintained between the biosynthesis, utilization and 
transportation of cholesterol, keeping its harmful deposition to a minimum. A possible 
method for ameliorating CHD is by reducing total serum cholesterol. Diet plays an 
important role in regulating this blood cholesterol level. 
Prophylactic and/or therapeutic value of fermented milk products has been 
reviewed extensively, since Metchnikoff mentioned the possible beneficial effects by the 
consumption of the same. Of the lactic acid bacteria used as a dietary adjunct maximum 
interest has been centered on L. acidophilus, a normal inhabitant of the intestinal tract. In 
North America, Bifidobacteria sp., which is also a natural inhabitant of intestine, has 
received recent attention. It prevails in the large intestine whereas lactobacillus is present 
in the small intestine. 
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Bifidobacteria were first identified in breast-fed infants by Tissier in 1899. 
Decreased infant mortality in breast-fed infants compared to bottle-fed infants was 
ascribed to the resistance offered by bifidobacteria. In addition, bifidobacteria can be 
isolated at any age from humans, however, difference in species exists. 
Bifidobacteria are unique; they lack both aldolase and glucose-6-phosphate 
dehydrogenase enzyme, therefore they do not metabolize carbohydrate by either glycolysis 
or the hexose monophosphate pathway. An alternate to these enzymes is fructose-6-
phosphate phosphoketolase (F6PPK) which cleaves ftuctose-6-phosphate into 
acetlyphosphate and erythrose-4-phosphate. This helps to distinguish this genera from the 
rest. Accordingly, the end product of carbohydrate metabolism is acetic acid and lactic 
acid (3:2 ratio) and small amounts of formic acid and alcohol. 
Certain factors are· to be considered for a culture to serve as a dietary adjunct. 
It should be a normal inhabitant of the intestinal tract, function by surviving and growing 
in the intestinal tract (bile tolerance), compete and grow well in the presence of similar 
bacteria and be viable in the carrier food. Some of the beneficial effects of bifidobacteria 
are due to their potential to produce antimicrobial activity, anticarcinogenic and 
antitumorgenic activity, alleviate lactose intolerance, synthesize vitamins and reduce levels 
of serum cholesterol. 
Considering the feasibility of using bifidobacteria in fermented milk products, 
the purpose of this project was to: (1) study the bile tolerance of B. longum; (2) study the 
factors affecting the amount of cholesterol taken up by B. longum; (3) measure the bile 
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salt dehydrogenase activity of B. longum; and ( 4) measure the cholesterol content in the 
cell membrane fraction of B. longum I. 
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CHAPTER II 
REVIEW OF LITERATURE 
In early 1900's Metchnikoffthought that aging and premature death caused 
by intestinal putrefaction could be prevented by ingestion of soy milk (45). Later in 1910, 
he suggested that the routine consumption of fermented milk is beneficial to the health of 
the consumer (62). Since then extensive research has focused on the possible therapeutic 
and prophylactic properties of certain cultured milk products. Lactobacillus acidophilus 
used in the manufacture of some cultured· milk products has received more attention in this 
regard than any other organism used in the manufacture of such products. However, over 
the past decade Bifidobacteria sp. has attracted a great deal of attention, since they also 
frequently are associated with potential health-promoting effects in human and animal 
intestinal tract, similar to those attributed to L. acidophilus. 
Occurrence and growth of bifidobacteria 
in human intestines 
Bifidobacteria were first isolated from the feces of infants and characterized in 
1899 by Henry Tissier (33, 45). They occur principally in the large intestine, especially in 
the area of the caecum (31, 37, 47, 62). The majority of them occupy the lumen of the 
5 
colon and the walls of the colon. While they occur in largest numbers in the large 
intestine, they have been detected throughout the intestinal tract (4, 45, 61). 
In infants bifidobacteria comprise a larger portion of the intestinal flora than in 
adults (47). In healthy breast-fed infants, one-fourth of the intestinal flora is 
bifidobacteria, whereas lactococci, enterococci and coliforms constitute less than 1 % of 
the total microflora with the absence of harmful bacteria like clostridia, proteus etc. (31, 
53). The numbers of bifidobacteria found in the feces of breast-fed infants were 
approximately 1011/g; the numbers decreased in adults to about 109/g (50). 
Changes in diet that occur as people age result in the decrease in numbers of 
bifidobacteria in the intestinal tract (31, 47). Even though the numbers decrease with age, 
bifidobacteria can be isolated from the feces of humans at any stage of life. Some of the 
frequently isolated species in infants are B. infantis, B. breve, B. bi.fidum and B. longum 
(45, 46, 47, 62). In adults, B. longum, B. adolescentis and B. bi.fidum are the most often 
encountered species (45, 46, 62). 
Pochart et al. ( 49) examined the ability of bifidobacteria to survive and/or grow 
in the upper gastro-intestinal tract of healthy human adults after ingestion of fermented 
milk containing Bi.fidobacteria sp. strain BB (2.5 x 107/g). The average number of viable 
bifidobacteria reaching the terminal ileum after 8 hr was 1 x 106 /ml of ileal fluid. In a 
similar study, after the consumption by healthy volunteers of fermented milk containing 
Bi.fidobacteria sp. strain BOSR (1.6 x 109/g), a mean of 6.3 x 108/g was recovered from 
the stool which represented a 20-fold increase of mean daily fecal excretion of 
bifidobacteria ( 6). 
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Clark et al. (10) analyzed the tolerance of B. longum, B. adolescentis, B. 
in/antis and B. biftdum in the simulated pH of human stomach. They found B. longum to 
have an excellent resistance at pH 1.0, 2.0 and 3.0 followed by B. in/antis and B. 
adolescentis at pH 2.0 and 3.0. However, survival of B. bifidum was poor at pH 1.0 and 
2.0. Additionally, Rao et al. (51) observed that microencapsulated B. pseudolongum 
survived in the simulated gastric environment in larger numbers than cells of non-
encapsulated strains. 
Survival and growth in the presence of physiological concentrations of bile salt 
is an important characteristic to be considered for the microorganisms to be used as 
dietary adjuncts (7, 24, 25). Ibrahim and Bezkorovainy (35) studied the growth of four 
Biftdobacteri11m sp. in the presence of 0, 0.06, 0.15 and 0.3% sodium glycocholate. A 
general trend of decrease in·rate of growth was observed with increasing concentration of 
bile salt for all four cultures. 
Potential health benefits from bifidobacteria 
Bifidobacteria potentially can have a hypocholesterolemic effect (33, 52), 
inhibit the growth of other microorganisms (2, 8, 33, 34, 50, 54, 59), directly and 
indirectly exert anticarcinogenic actions (21, 30, 33, 36, 41, 54) and improve lactose 
utilization in lactose malabsorbers (1, 28). Thus there is considerable interest in their use 
as dietary adjuncts for humans. 
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Control of serum cholesterol 
Cholesterol is an important constituent in maintaining the rigidity and fluidity 
of the membrane in eukaryotes (66). Sources of cholesterol in the body include that 
synthesized in the liver from acetyl co-A and, to a lesser extent, that absorbed from the 
intestine from food. On contrary to its benefits, high levels of blood cholesterol are 
related to cardiovascular disease and coronary heart disease (39). Thus there is interest in 
ways to control levels of serum cholesterol in hypercholesterolemic persons. 
Consumption of certain cultured or culture containing milk products has resulted in 
reductions in serum cholesterol in humahS (27, 40, 52) as well as in animals (14, 17, 26, 
33). 
Mann and Spoerry (40) found that consumption of fermented milk prepared 
with wild type Lactobacillus, by the Maasai people, led to lower levels of cholesterol in 
the blood. They suggested that the lactic acid bacteria produced hydroxymethylglutarate 
(ITh1G) during fermentation of the milk, which inhibited HMG-Co A reductase involved in 
cholesterol synthesis in the body. Hughes and Hoover (33) suggested that lowered serum 
cholesterol brought about by feeding bifidobacteria might have involved HMG co-A 
reductase. 
A significant reduction in levels of serum cholesterol and triglycerides was 
observed in humans suffering from elevated serum cholesterol levels following 
consumption of bifidobacteria (52). Rasic et al. (52) reported that cholesterol was 
assimilated by B. bifidum in laboratory media. The degree of uptake varied from strain to 
strain. Homma (28), in an in vitro study of the effect of bifidobacteria on cholesterol 
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metabolism of human lymphocytes suggested that bifidobacteria retarded the formation of 
LDL receptors and thus reduced cholesterol synthesis. 
Harrison et al. (27) observed lower levels of serum cholesterol in conjunction 
with increased numbers of lactobacilli in the stools of infants fed milk based formula 
containing L. acidophilus compared to ones receiving control formula. The researchers 
speculated that the lactobacilli caused the effect on levels of serum cholesterol. 
Grunewald (26) observed a reduction in serum cholesterol levels in rats after 
feeding milk fermented with L. acidophilus compared to rats fed non-fermented milk. 
Gilliland et al. (25) reported that pigs on a high cholesterol diet fed cells of a strain of L. 
acidophilus that assimilated cholesterol in laboratory media had significantly lower levels 
of serum cholesterol than did pigs on the same diet without L. acidophilus. In another 
study, decrease in the concentrations of total serum cholesterol and low-density 
lipoprotein cholesterol were observed in boars on high cholesterol diet when fed 
acidophilus yogurt (14). De Rodas (17) reported a significantly greater decrease in serum 
cholesterol when pigs with diet induced hypercholesterolemia were fed L. acidophilus 
than in those not receiving L. acidophilus. 
Buck and Gilliland (7) observed removal of cholesterol from the laboratory 
media by strains of L. acidophilus isolated from the fecal flora of human volunteers. 
Significant variation occurred among the strains in the ability to assimilate cholesterol. 
Gilliland et al. (25) demonstrated that isolates of L. acidophilus from pigs grown under 
anaerobic condition in the presence of cholesterol and bile salts assimilated a portion of 
the cholesterol from the laboratory media. A strain which did not assimilate cholesterol 
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from laboratory media was not effective in helping control serum cholesterol in pigs. 
While these cultures varied in tolerance to bile acid, there was no direct relationship 
between the bile tolerance and the ability to assimilate cholesterol (24, 25). In a similar 
study, no significant correlations were observed among bile tolerance, ability to 
deconjugate bile acid and assimilation of cholesterol (67). 
The ability of lactobacilli and related intestinal bacteria to deconjugate bile 
acids in the small intestine is another activity of these bacteria that may be important in 
controlling serum cholesterol levels (22). Gilliland and Speck {23) reported laboratory 
strains of L. acidophilus deconjugated both glycocholic and taurocholic acids. Buck and 
Gilliland (7) and Walker and Gilliland (67) reported variations among strains of L. 
acidophilus with respect to relative abilities to deconjugate bile acids and to assimilate 
cholesterol. However, the two activities were not related. De Rodas {17) on the other 
hand, reported a significant relationship between deconjugation of bile acids in the 
intestine and reductions in serum cholesterol level caused by consumption of L. 
acidophilus. Hence suggested the importance of deconjugation in lowering 
concentrations of serum cholesterol. 
Bifidobacteria also can deconjugate bile acids. B. adolescentis hydrolyzed only 
glycine conjugates whereas B. bi.fidum and B. longum hydrolyzed both glycocholic and 
taurocholic acids. Chikai et al. (9) reported that B. longum and B. vulgatus preferentially 
deconjugated taurcholic acid and tauro-13-muricholic acids respectively, whereas 
Clostridium ramosum deconjugated both glycine and taurine conjugated bile acids. 
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Antimicrobial effects 
Bifidobacteria exert antagonistic action towards growth of enteric pathogenic 
bacteria and other bacteria. Those inhibited by bifidobacteria include Escherichia coli, 
Bacillus cereus, Salmonella typhosa, Staphylococcus aureus, Shigella dysenteriae, 
Psuedomonasjluorescens andMicrococcusjlavus (2, 8, 33, 50, 54). 
The antimicrobial activity of bifidobacteria has been attributed to their 
production of acetate and lactate along with small amounts of formate from fermentation 
of carbohydrates ( 47, 50). The intestinal pH lowered by the production of acetic acid 
along with lactic acid can have an inhibitory effect on species of Escherichia, Clostridium, 
Shigella and Salmonella (28). 
Anand et al. (2) reported that Bi.fidobacterium bi.fidum was inhibitory towards 
E. coli, B. cereus, S. typhosa, S. aureus, S. dysenteriae, Ps. fluorescens and M jlavus in 
laboratory media. The authors inferred that inhibition was due to the presence of some 
antibacterial substance(s) other than the acid produced from fermentation of sugars. 
Children with various gastrointestinal problems to whom milk containing 
bifidobacteria was administered, exhibited increased weight gain and resistance to 
infection (36). Colombe! et al. (12) examined the antidiarrheal effect of bifidus yogurt in 
erythromycin-induced gastroenteritis in adults. Abdominal discomfort was noticed only in 
10% of the treated group after consuming bifidus yogurt containing B. longum compared 
to all of the control group. The ingestion of B. bi.fidum in combination with lactulose by 
children suffering from enteric infections led to eradication of E. coli in more than 80% of 
the cases studied (54). 
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Mice fed B. longum lived longer after intragastric or intravenous administration 
of a lethal dose of pathogenic E. coli or an intravenous injection of the endotoxin than did 
mice not fed the bifidobacteria (59). No clinical signs of pathogenic effect were observed 
when B. longum or mixtures of B. longum and E. coli were fed to gnotobiotic mice 
compared to the control (47). 
Bifidobacteria can stimulate the host's immune system which can aid in the 
control of intestinal pathogens. An immune response was produced through increased 
secretion of immunoglobin A in monoassociated mice fed B; longum (28, 36). This 
immunoglobin A prevents the absorption of antigens by the mucosal epithelium by acting 
as a barrier to the foreign matter. 
Strains ofbifidobacteria that attach to epithelial cells significantly interfere with 
the attachment of enteropathogenic microbes and/or their toxins onto human epithelial 
cells (5, 62, 68). This represents another possible mecha~sm where by the bifidobacteria 
can control intestinal infections. 
Some have speculated that bifidobacteria produce an antimicrobial like 
substance having properties of bacteriocin (2, 34, 43). This substance was found to be 
heat stable, active at pH 2,.10 and active against other gram-positive bacteria such as other 
bifidobacteria, lactobacilli, clostridia and some streptococci ( 43). Anand et al. (3) 
reported that B. bi.ftdum produces such a substance which can be stored at 4-5°C for more 
than three months without affecting its inhibitory activity. 
12 
Anticarcinogenic activity 
Bifidobacteria may be able to exert some control on certain types of cancer. 
Feeding cells of B. bifidum to mice having tumor cells was followed by reduction in the 
number of tumor cells (54). In another study, when mice were administered cells of B. 
breve and fiuctooligosaccahrides there was a reduction in excreted carcinogens (33). The 
presence of E. coli, Enterococcus fecalis and Clostridium paraputrificum in the intestine 
of the mice was associated with the development of liver tumors (33). However, in the 
presence of B. longum proliferation of the tumors decreased. 
Whole cells of B. in/antis as well as the cell walls contain an antitumor 
constituent (21). Hence, injecting cell wall fractions of B. in/antis into the growing 
tumors of mice increased the immune response (36, 54). In addition, ingestion of dead or 
live cells ofbifidobacteria reduced tumor formation in mice and also the lethal effects (30). 
Improved lactose utilization 
Another potential health benefit of consuming bifidobacteria is their ability to 
breakdown lactose which is beneficial for lactose malabsorbing persons. Lactose 
maldigestion is due to insufficient amounts of ~-galactosidase in the small intestine to 
hydrolyze lactose. Since bifidobacteria are resistant to bile and can hydrolyze lactose they 
can grow in the intestine to provide ~-galactosidase to facilitate digestion of lactose (28, 
33). 
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Cholesterol in bacterial membranes 
Cholesterol is an integral part of the membrane in the eukaryotic cells. It is 
believed to maintain the structural rigidity and fluidity by its plasticizer effect (32). 
Mycoplasma are unique organisms among prokaryotes because they do not 
have a cell wall. Cholesterol in their membranes is said to increase the tensile strength of 
the membrane (55). This permits their growth and survival without cell walls. Since they 
lack the ability to synthesize cholesterol, they require an external source of cholesterol for 
growth (29, 55, 58). Mycoplasmas when grown in the presence of cholesterol incorporate 
it into their cell membranes without any alteration (29, 63, 65). Incorporation is largely 
dependent upon the composition of other lipids and phospholipids of the membrane (56). 
Mycoplasma capricolum when grown in the presence of horse serum (4%) 
incorporated 127 µg cholesterol/mg of membrane protein (44). Dahl et al. (13) observed 
an increase in cholesterol content of M capricolum membranes from 14 to 28 mol % of 
the total lipid with corresponding increase in viscosity. Clejan et al. (11) reported an 
increase from 28 to 127 µg cholesterol/mg of membrane protein in 5 hr in the presence of 
10% fetal calf serum inM capricolum. 
Mycoplasma gallisepticum when grown m the presence of cholesterol 
incorporated 52% of unoxidized cholesterol into their membrane (29). On the other hand, 
assimilation of oxidized cholesterol into the membrane had inhibitory effects in the growth 
of mycoplasma. 
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Osmotic stability of liposomes prepared with membrane lipids of M orale was 
greater because of cholesterol and in S. aureus due to the presence of cardiolipin ( 48). 
The presence of cholesterol was found to decrease the transport of branched-chain amino 
acid, lysine, in membrane vesicles of S. cremoris (69). 
Razin (57) reported incorporation of cholesterol by gram-positive bacteria, 
including Micrococcus lysodeikticus, Bacillus megaterium and Proteus mirabilis, when 
grown in the presence of cholesterol. However, the quantity incorporated was much less 
than observed for the mycoplasmas. In another study, membrane fluidity was reduced in 
Bacillus megaterium by incorporated cholesterol (63). Similarly, E. coli TB4 
incorporated 0.147 mg of cholesterol/mg of protein in the membrane when grown in the 
presence of cholesterol at 37°C which caused a large decrease in the membrane fluidity 
(19). 
Relationship between cholesterol and bile acids 
Cholesterol is a vital constituent of cell membranes and the precursor of steroid 
hormones and bile acids (60, 66). Even though it is quite essential to life, its deposition in 
arteries has been associated with heart disease and atherosclerosis, two leading causes of 
death in humans. 
Enterohepatic Circulation of 
Cholesterol and Bile acid 
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Most of the endogenous cholesterol is synthesized in the liver and to a lesser 
extent in the intestine (60, 66). The liver is the only organ which has the capability to 
synthesize bile acids from cholesterol. The conversion of cholesterol to bile acids in the 
liver involves (1) saturation of the 5,6-double bond, (2) epimerization of the 3f3-0H 
group, (3) introduction of OH groups into 7a and 12a positions; and (4) oxidation of C 
number 24 to carboxylate (60, 66). Conjugation of C number 24 with glycine or taurine 
results in respective conjugated bile acids. This accounts for 30-60% of the cholesterol 
utilized in the human body (60). 
A substance is said to undergo an enterohepatic circulation when it is 
metabolized in the liver, excreted into the bile, passed into the lumen of the intestine, 
reabsorbed through the intestinal wall and then returned to the liver in the portal 
circulation (60). Cholesterol in the liver is converted into primary bile acids namely cholic 
acid and chenodeoxycholic acid (15, 18, 20). These are conjugated with the amino acid 
glycine or taurine to form respective conjugated bile acids. These bile acids are then 
stored in the gallbladder and released into the duodenum in response to a meal (42, 53, 
66). The principle function of conjugated bile acids is to emulsify lipids and aid in efficient 
dispersion and absorption in the upper part of the small intestine. These bile acids are 
returned to the liver following reabsorption from the small intestine into the blood and 
back to the liver for reuse (45, 53, 60, 66). 
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In the small intestine, approximately 80-95% of the bile salts undergo the 
enterohepatic circulation by absorption through the wall of the small intestine (42, 45, 53). 
The remaining bile acids that escaped enterohepatic circulation are excreted through the 
feces which is the only route for cholesterol elimination from the body (15, 16, 20, 66). 
The fraction of the bile acid pool lost from the enterohepatic circulation is replaced by de 
nova synthesis of bile acids each day (38). 
Bile salt hydrolase is the key bacterial enzyme for deconjugation of conjugated 
bile acids and it is synthesized constitutively (23, 42, 64). It is an extracellular enzyme in 
bifidobacteria which deconjugates bile acids to release cholic and chenodeoxycholic acids. 
These unconjugated secondary and tertiary bile acids are excreted more rapidly than 
conjugated ones (9). Thus deconjugation of bile acids can increase their excretion. This 
in tum increases the catabolism of cholesterol into bile acids and thus can reduce the pool 
of cholesterol in the body. 
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Four strains of B. longum isolated from feces of human volunteers were tested 
along with four commercially available strains of B. longum for bile tolerance, the ability 
to deconjugate sodium taurocholate and the ability to assimilate cholesterol. The cultures 
varied with respect to each test. There appeared to be no relationship between bile 
tolerance and ability to assimilate cholesterol. Relative amounts of deconjugation of 
sodium taurocholate also were· not related directly to the amount of cholesterol assimilated 
by the cultures. However, inclusion of sodiµm taurocholate in the growth medium 
enhanced the ability of B. longum to remove cholesterol from the medium during growth. 
A portion of the cholesterol removed from the growth medium by B. longum was 
recovered in the cellular membrane fraction suggesting some assimilation of cholesterol 
into the membrane. Cells grown in the presence of cholesterol and taurocholate were 
more resistant to sonication than were those grown in the control broth and in broth 
containing the bile salt without cholesterol. This is further evidence that cell membrane 
was affected by the cholesterol. 
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INTRODUCTION 
Coronary heart disease is one.of the leading causes of death (42%) in the 
United States (38). Elevated levels of serum cholesterol have been associated with the 
occurrence of coronary heart disease (22). Thus, there has been much interest in reducing 
this risk by lowering serum cholesterol levels. 
The consumption . of milk products containing some lactobacilli or 
bifidobacteria can have a beneficial effect in lowering concentrations of serum cholesterol 
(6, 7, 11, 12, 13, 16, 18, 23, 26). Assimilation of cholesterol during growth by L. 
acidophilus has been observed by some researchers (2, 6, 10, 11, 40), an activity 
providing potential for helping control serum cholesterol if it occurs in the intestine. On 
the contrary, only a few reports have shown the potential hypocholesterolemic effect of 
bifidobacteria {16, 26, 35). Consumption of B. bifidum, shown to assimilate cholesterol in 
laboratory tests, for 6 weeks resulted in reduction of levels of serum cholesterol in humans 
having elevated levels of serum cholesterol {26). 
Deconjugation of bile acids and excretion of the resulting free bile acids can 
result in reduction of serum cholesterol (8, 33). Chikai et al. (3) and Eyssen (8) observed 
greater excretion of bile acids, mostly deconjugated, in conventional animals than in germ-
free animals. When fed to germ free rats, B. longum deconjugated taurine-conjugated bile 
acids and caused increased excretion of free bile acid (3, 17, 20). The increased excretion 
of bile acids has the potential to lower serum cholesterol concentrations, since their 
replacement would require utilization of some cholesterol in the body. 
Mycoplasma sp. are unique prokaryotes which do not posses a cell wall. 
Cholesterol in their membranes increases the tensile strength of the membrane enabling 
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them to survive without cell walls (27, 41). They lack the ability to synthesize cholesterol, 
therefore require cholesterol in the growth media which is incorporated into their cell 
membranes (4, 5, 14, 24, 29). Micrococcus lysodeikticus and Bacillus megaterium also 
incorporate cholesterol into their cellular membrane during growth in the presence of 
cholesterol (28, 36). Lactobacillus acidophilus also incorporates it into the membrane 
during growth (25). 
The purpose of this study was to determine whether or not cholesterol 
assimilation by B. longum was related to bile salt deconjugation and if it was incorporated 
into the membrane. 
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MATERIALS AND METHODS 
Source and Maintenance of Cultures 
An agar medium containing a mixture of chemicals selective for bifidobacteria 
(21) was utilized to isolate cultures of B. longum. The base medium was MRS agar 
prepared by dissolving agar (1.5%) in lactobacilli MRS broth (Difeo Laboratories, Detroit, 
MI) prior to sterilization (15 min at 121°C). Just prior to use, an aqueous solution 
(rendered free of bacterial cells by passage through a sterile 0.45µ membrane filter) 
containing sufficient amounts of neomycin sulfate, paramycin sulfate, nalidixic acid and 
lithium chloride was added to 100 ml of melted agar to yield final concentrations of 6 
mg/100 ml, 12 mg/100 ml, 0.9 mg/100 ml and 180 mg/100 ml respectively. 
Human fecal samples were provided by three volunteers on sterile dacron 
swabs (Fisher Scientific Co., Pittsburgh, PA) in 10 ml volumes of lactobacilli MRS broth 
containing 0.2% sodium thioglycolate (Sigma Chemical Co., St. Louis, MO). This broth 
was referred to as MRS-THIO broth. The tubes containing the fecal samples were held in 
a refrigerator in an ice-water mixture for not more than 48 hours before microbiological 
analysis was done. The tubes containing the samples were vortexed (Fisher Scientific Co., 
Model 232) for approximately 15 seconds then appropriate dilutionswere made using 1% 
peptone dilution blanks (39) and plated using the spread plate method onto plates of the 
selective agar medium. The plates were incubated for 48 hours at 37°C in a Gas Pak 
(Baltimore Biological Laboratories, Dickinson and Company, Maryland) anaerobic 
system. Following incubation, ten isolated colonies were picked using sterile inoculating 
needles and transferred into sterile tubes of MRS-THIO broth. The tubes were incubated 
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at 37°C until growth was indicated by turbidity. The isolated cultures were identified as 
described below. Those identified as B. longum were used for further study. 
Three other strains of B. longum (I, II, III) were obtained from commercial 
suppliers and one (ATCC 15707) from the American Type Culture Collection. All 
cultures were maintained by subculturing (1 % inoculum) into lactobacilli MRS-THIO 
broth incubating 16 fo 18 hours at 37°C. The cultures were stored at 5 to 7°C between 
transfers. Prior to experimental use each culture was subcultured at least two times. 
Identification of Cultures 
Preliminary identification of the cultures was based on catalase test, gram-stain 
reaction and the presence or absence of fructose-6-phosphate phosphoketolase (15). 
Cultures composed of catalase negative, gram-positive rod. shaped cells and positive for 
fructose-6-phosphate phosphoketolase were considered to be bifidobacteria. Additional 
characteristics were · determined using API-50 CH kits (bioMerieux Vitek Inc., 
Hazelwood, MO). For this, cells were harvested from 10 ml MRS-THIO broth cultures 
by centrifugation (10 min at 12,000 x g at 4°C). The cells were washed once with 10 ml 
of sterile 0.75% sodium chloride solution (Fisher Scientific Co.) and resuspended in 5 ml 
of the same solution. The API-50 CH kits were inoculated using the cell suspensions 
following the manufacturer's direction except mineral oil was not added to each test well. 
The inoculated kits were incubated in a Gas Pak anaerobic system for 48 hours at 37°C. 
Determination of the species was accomplished by comparing observed reactions with 
those given in the ninth edition of Bergey's Manual of Systemic Bacteriology (15). 
Comparison for Bile Tolerance and 
Bile Salt Deconjugation 
The bile tolerance of each culture was measured by the procedure described by 
Gilliland and Walker (10), except MRS-THIO broth was used in place of MRS broth. 
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Results were expressed as hours required for the optical density (O.D.) at 620 nm to 
increase by 0.3 units. The bile salt deconjugation ability of the cultures was based on 
deconjugation of sodium taurocholate ( 40). Results were expressed as cholic acid 
released (mmoles/ml) during 18 or 24 hour incubation at 37°C. 
Measurement of Cholesterol Assimilation 
Sterile MRS-THIO broth was supplemented with the desired amount of 
sodium taurocholate (Sigma Chemical Co.). The sodium taurocholate solution was 
filtered through a sterile 0.45µ membrane filter prior to use. The broth was freshly 
prepared on the day of the experiment. 
For each culture to be tested, one ml of cholesterol-phosphatidylcholine 
micelles prepared according to Razin et al. (30) was added to 9 ml of the MRS-THIO 
broth containing sodium taurocholate. Following mixing, 2 ml of the broth was removed 
into a sterile test tube and held as an uninoculated control. The remaining broth was 
inoculated (1%) with a freshly grown culture and incubated for the desired time in a water 
bath maintained at 37°C. After incubation cells were removed by centrifugation for 10 
min at 12,000 X g and 4°C. 
The o-phthaladehyde method (32) was used to measure cholesterol in the spent 
broth and uninoculated control broth. The amount of cholesterol assimilated ( expressed in 
µg/ml) was determined by subtracting the amount remaining in the spent broth from that 
in the uninoculated control. In order to measure the cholesterol associated with the cells, 
the pellet from the culture was resuspended in a volume of distilled water equal to that of 
the original culture and assayed by the o-phthaladehyde method. 
Cholesterol Assimilation During Growth at pH 6.5 
MRS-THIO broth (450ml) supplemented with 0.006 M sodium taurocholate 
and cholesterol-phosphatidylcholine micelles (lOOµg cholesterol/ml) was placed in a 
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fermentor of about one liter capacity equipped with a pH electrode and ports for the 
addition of neutralizer and sparging with nitrogen gas (from bottom to top). The entire 
assembly containing the broth was autoclaved 15 min at 121 °C. The fermentor was then 
placed in 37°C water bath and connected to an automatic pH controller (Model 5997, 
Horizon Ecology Co., Chicago, IL) which was adjusted to maintain the broth at pH 6.5. 
The neutralizer for the pH control unit was prepared by adding 5% ammonium hydroxide 
to a sterile solution of 5% sodium carbonate (9). After mixing the broth for 2-3 min, 10 
ml of the broth was withdrawn aseptically using syringe and placed in a sterile screw cap 
test tube to serve as an uninoculated control. The remaining broth was inoculated with 5 
ml of a freshly grown MRS-TIDO broth culture of B. longum I. Nitrogen gas was 
sparged through the broth continuously at the flow rate of 5 cc/min. Following 18 hour 
incubation, a 10 ml sample was withdrawn and centrifuged (10 min at 12,000 x g at 4°C) 
to remove the cells. The spent and uninoculated control broths were assayed for 
cholesterol (32). A static culture (without pH control) in the same medium but without 
being sparged with nitrogen was incubated along side the culture being grown at pH 6.5 
for comparison. 
Isolation of Cellular Membrane 
B. longum I cells were grown in 200 ml of MRS-TIDO broth supplemented 
with 0.006 M sodium taurocholate and cholesterol-phosphatidylcholine micelles (100 µg 
cholesterol/ml). After 18 hour of incubation, the cells were harvested by centrifuging at 
12,000 x g and 4°C for 10 min. The cell pellets were washed with distilled water and 
membrane isolation was carried out according to the method described by Thome and 
Barker (37). The washed cells and membrane fractions were assayed for cholesterol (32), 
ATPase activity and protein content. 
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ATPase Activity and Protein Measurement 
Adenosine triphosphatase (ATPase) activity was assayed by the method 
described by Rottem and Razin {31). The specific ATPase activity was expressed as 
µmoles of inorganic phosphate released per mg protein/min. The protein content was 
measured by the method of Bradford (1) using human albumin (Sigma Chemical Co.) as a 
standard. 
Resistance of Cells to Sonic Disruption 
B. longum I was grown m MRS-TRIO (Medium A); MRS-TRIO 
supplemented with 0.006 M sodium taurocholate (Medium B) and MRS-THIO 
supplemented with 0.006 M sodium taurocholate and cholesterol-phosphatidylcholine 
micelles {lOOµg cholesterol/ml) (Medium C) for 18 hours in a 37°C water bath. Cells 
were recovered by centrifugation at 12,000 x g and 4°C for 10 min. Each cell pellet was 
resuspended in distilled water to yield a density of . approximately 2. 5 x 109 cells/ml. 
Twenty ml volumes of cell suspensions were transferred to 50 ml beakers placed in an ice-
water bath and sonicated for 10 min in a Sonic Dismembrator (Fisher Scientific, 
Pittsburgh, PA) adjusted to a maximum output. The number of intact cells were counted 
at O and 10 min by direct microscopic count (39). Results were expressed as percentage 
of cells lysed. 
Statistical Analysis 
All experiments were replicated three times. Analysis of variance for 
randomized complete block was used to determine if significant variation occurred among 
culture means in each experiment. Least significant difference test was used to determine 





The identification characteristics of each culture used in this study are listed in 
Tables A. I and A.2 of the appendices. Each of the commercial strains (I, II and 111) and 
ACT 15707 were confirmed to be B. longum based on identity characteristics published in 
Bergey's Manual of Systemic Bacteriology (15). Four cultures from intestinal samples 
from 3 different persons were identified as B. longum. These were included in the study. 
Bile Tolerance 
Variations were observed among strains with respect to growth in MRS-TIIlO 
supplemented with 0.3% oxgall (Table I). The times for the O.D. to increase by 0.3 units 
in the presence of 0.3% oxgall varied from 4.56 hr (strain I) to greater than 10 hr (strain 
III). Strain I was significantly (P < 0.05) more bile tolerant than strains KS, LS, II and III 
but not from strains S9, ATCC 15707 and S12. Strain III was significantly (P < 0.05) less 
bile tolerant than all other strains tested. 
Influence of Sodium Taurocholate on 
Assimilation of Cholesterol 
The amount of cholesterol removed ( assimilated) from the growth medium by 
B. /ongum S9 was influenced by the concentration of sodium taurocholate in the medium 
(Table II). The amount of cholesterol removed increased with increasing concentrations 
oftaurocholate from 0.0 M to 0.006 M then declined as the concentration of taurocholate 
increased beyond 0.006 M. Of the concentrations tested, significantly (P < 0.05) more 
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cholesterol was assimilated from the media containing 0.006 M taurocholate than from 
media containing any other concentration. 
Simultaneous Screening for Bile Salt Hydrolase Activity 
and Assimilation of Cholesterol 
Initially the eight strains were compared in two groups of four simultaneously 
for bile salt hydrolase activity and ability to assimilate cholesterol from the growth media, 
during 24 hours of incubation at 37°C (Table B.3 and B.4 of the appendices). Minimal 
differences in bile salt deconjugation were observed except strain III was significantly (P < 
0.05) less active than I, II and ATCC 1.5707. Strains S9, S12, KS and LS did not differ (P 
< 0.05) in amounts of deconjugation. The four strains that assimilated the most 
cholesterol (I, II, S9, ATCC 15707) were reassayed as a group using 18 hour incubation. 
Though the strains did not differ significantly (P > 0.05) in the ability to deconjugate 
sodium taurocholate (Table III), they did vary significantly (P < 0.05) in the amount of 
cholesterol assimilated. There was no significant difference between the amounts 
assimilated by strains I and II. However, both assimilated more (P < 0.05) cholesterol 
than did either strains S9 or ATCC 15707. The latter two strains did not differ (P > 0.05) 
in the amount assimilated. 
There was no apparent relationship between the amounts of cholesterol 
assimilated and the amounts of bile salt deconjugated. 
Cholesterol Uptake byB. longum I During Growth at pH 6.5 
Some researchers (19) have suggested that removal of cholesterol from media 
containing cholesterol and conjugated bile salts by bifidobacteria results from it being 
coprecipitated with free bile salts released from deconjugation of the bile acid during 
growth of the organism. Since cholic acid released through deconjugation of taurocholate 
precipitates at pH below 6.0 (19), experiments were conducted in which the growth 
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medium was maintained at pH 6.5 throughout the growth period. During 18 hr of 
incubation more cholesterol (P < 0.05) was assimilated by B. longum I when grown at pH 
6.5 than when grown as a static culture without pH control (Table IV). 
Cholesterol in the Membrane Fraction of B. longum I 
Cholesterol was measured in the membrane fraction of B. longum I after 
growing for 18 hour at pH 6.5 (Table V). The amount of cholesterol associated with the 
membrane was expressed as µg of cholesterol/mg of protein. The specific activity of the 
ATPase was significantly (P < 0.05) higher in the membrane fraction than in the washed 
cells showing that much of the non-membrane components of the cells had been removed 
during the isolation procedure. Significantly (P < 0.05) more cholesterol per mg protein 
was detected in the washed whole cells than in the membrane fraction. Thus, even though 
cholesterol was detected in the membrane, much of that associated with the cells 
ap,parently was not in the membrane. 
Resistance of B. longum I to Sonic Disruption 
Cells of B. longum I grown in medium C which contained both cholesterol and 
sodium taurocholate were significantly (P < 0.05) more resistant to lysis by sonication than 
were cells grown in either of the other media without cholesterol (Table VI). Cells grown 
in MRS-THIO (Medium A) and in MRS-THIO containing sodium taurocholate (Medium 
B) did not differ (P > 0.05) in their resistance to lysis by sonication; 91.1 % and 91.6% 
lysis was observed for these media respectively. However, only 85% (P < 0.05) of the 




Previous studies have shown the need for bile salts in order for lactobacilli to 
assimilate cholesterol (2, 10, 11, 19). Data from the present study shows the importance 
of bile salts in enhancing the removal of cholesterol from growth media by B. longum. 
Growth is required for this phenomenon (3 5), thus the organism must be able to grow in 
the presence of bile. The degree of bile tolerance (i.e. measured as growth in media 
containing 0.3% oxgall) varied among strains of B. longum included in this study. The 
ability to assimilate cholesterol also varied among strains. However, the most bile tolerant 
strains did not necessarily assimilate the most cholesterol. For example, strain II was 
significantly less bile tolerant than strain S9, however it assimilated significantly more 
cholesterol than did S9. Thus a culture with high bile tolerance does not necessarily 
assimilate more cholesterol than one with lower bile tolerance. 
Gilliland et al. (11) indicated that cholesterol removed from laboratory media 
during growth of L. acidophilus was assimilated by the culture. Klaver and van der Meer 
(19) on the other hand· suggested that the cholesterol merely co-precipitated along with 
free bile acids released through deconjugation of conjugated bile acids in the growth 
medium. This was based largely on their observation that no cholesterol was removed 
when the growth medium was maintained at pH 6.0 which would prevent the precipitation 
of free bile acids. However, in the present study chol.esterol was removed from the 
growth medium by B. longum during growth at pH 6.5. Furthermore, there appeared to 
be no relationship between the amount of cholesterol assimilated and the degree of bile 
salt deconjugation. Tahri et al. (35) reported that the removal of cholesterol from the 
growth medium by bifidobacteria was not entirely due to its precipitation. 
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Less cholesterol uptake was observed when B. longum was grown statically 
without pH control compared to the amount taken up in a culture maintained at pH 6.5. 
This could be due to greater growth of the culture in the medium at pH 6.5 than in the 
static culture or perhaps the agitation required for pH control facilitated better continuous 
contact between the cells and cholesterol micelles. Assay of membrane fractions isolated 
from cells of B. longum grown in the presence of cholesterol at pH 6.5 revealed 
cholesterol to be associated with the membrane. The fact that less cholesterol per mg 
protein was detected in the membrane fraction than in the whole cells suggests much of 
the cholesterol was not closely associated with the membrane. It may have been 
intracellular or merely adsorbed onto the cell surface. 
The greater resistance to lysis by sonication of cells grown in the presence of 
cholesterol compared to those grown in its absence suggests differences in the cell 
membrane. Mycoplasma sp. require cholesterol for their growth which is incorporated 
into their membranes (4, 5, 14, 24, 28, 29). This increases the tensile strength of the 
membranes (27, 41). It may have a similar effect on the membrane of the bifidobacteria. 
In summary, growth of B. longum in media containing cholesterol and sodium 
taurocholate resulted in part of the cholesterol being removed along with the bacterial 
cells. This removal was not related directly to the ability of the culture to deconjugate free 
bile acids that would cause the cholesterol to co-precipitate as the growth medium reached 
pH of less than 6.0. A part of the cholesterol removed from the growth media by B. 
longum was assimilated into the membrane. This incorporation appeared to increase 
resistance of the cells to sonic disruption. The strains of B. longum included in this study 
did not appear to be as active in removing cholesterol from a laboratory growth medium 
as has been reported for selected strains of L. acidophilus (2, 40). Thus, if this activity is 
important in having beneficial effect on serum cholesterol the bifidobacteria may not be the 
best choice of a culture for such use. 
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COMPARISON OF GROWTH OF STRAINS OF B. longum 
IN BROTH SUPPLEMENTED WITH 0.3% O?(GALL 
Strains of B. longum Bile Tolerance1'2 
13 4.56 
S9 5.26a,b 






Time in hours for the culture to increase the O.D. by 0.3 at 620nm at 37°C in 
MRS-THIO broth containing 0.3% oxgall. · 
Values are the means of three replications. Means with no common 
superscript letters differ significantly (P < 0.05). S.E. = 1.29; 12 df. 
Commercial cultures. 
TABLE II 
INFLUENCE OF SODIUM TAUROCHOLATE ON 
ASSIMILATION OF CHOLESTEROL 
BY B. longum S9 
Sod. Taurocholate1 Cholesterol Assimilated2•3 







1 Molar concentration of sodium taurocholate in MRS-THIO broth containing 
cholesterol (83.14µg/ml) as cholesterol-phosphatidylcholine micelles. 
2 µg/ml of cholesterol assimilated by the culture during 24 hr growth at 37°C. 
3 Values are the means of three replications. Means with no common 
superscript letters differ significantly (P < 0.05). S. E. = 7.40; 7 df 
42 
TABLE III 
ASSIMILATION OF CHOLESTEROL AND BILE SALT DECONJUGATION 
BY SELECTED STRAINS OF B. longum1 
Culture Cholesterol Bile salt 
Assimilated2' 4 Deconjugated3' 4 
II 34.143 2.893 
I 31.05a 2.933 
S9 22.47b 2.658 
ATCC 15707 21.36b 2.963 
43 
1 During 18 hr growth at 37°C in l\1RS-TIDO containing cholesterol (87.38µg/ml) 
as cholesterol-phosphatidylcholine micelles and 0.006 M sodium taurocholate. 
2 µg/ml of cholesterol assimilated. S.E. = 10.33; 6 df 
3 mmoles/ml of cholic acid liberated. S.E. = 0.11; 6 df 
4 Values are the means of three replications. Means with no common superscript 
letters differ significantly (P < 0.05). 
TABLE IV 
ASSIMILATION OF CHOLESTEROL BY B. longum I 
DURING GROWTH1 WITH AND WITHOUT 








1 During 18 hr growth at 37°C inMRS-THIO containing cholesterol (97.66µg/ml) 
as cholesterol-phosphatidylcholine micelles and 0.006 M sodium taurocholate. 
2 Values are the means of three replications. Means with no common superscript 





CHOLESTEROL CONTENT AND ATPase ACTIVITY 
OF CELLS AND MEMBRANE OF B. longum 11 
Fraction 








Cells were grown with control of growth medium (pH 6.5) in :MRS-THIO 
containing cholesterol (81.48µg/ml) as cholesterol-phosphatidylcholine 
micelles and 0.006 M sodium taurocholate for 18 hr at 37°C. 
µg of cholesterol/mg of protein. S.E. = 702.62; 2df 
The specific ATPase activity is expressed as µmoles/min/mg protein. 
S.E. = 0.00; 2 df 
4 Values are the means of three replications. Means in the same column with no 




COMPARISON OF CELL L YSIS BY SONICATION OF 
CELLS OF B. longum 11 
Growth Medium2 Additive % Lysis3 
A None 91.2a 
B Sodium Taurocholate4 91.7a 
C Sodium Taurocholate4+ Cholesterol5 85.0h 
46 
Cells harvested after 18 hr growth in the indicated medium at 37°C and sonicated 
with Sonic Dismenibrator for 10 min after resuspending the cells in water to have 
an initial count of2.5 X 109 cfu/ml (0% lysis). Number ofnonlysed cells were 
counted by Direct Microscopic Count method and results are expressed in terms 
of percentage of lysis. 




Values are the means of three replications. Means with no common superscript 
letters differ significantly (P < 0.05). S.E. = 2.77; 6df. 
0.006 M sodium taurocholate. 




APPENDIX A: IDENTIFICATION CHARACTERS 
TABLEA.1 IDENTIFICATION CHARACTERISTICS OF FRESHLY 
1 
ISOLATED STRAINS OF Bifidobacterium longum1 . 
API Tests2 Bergey3 S9 S12 KS LS 
L-Arabinose + + + + + 
Ribose + + + + + 
D-Xylose +/- + + + + 
Galactose + + + + + 






Maltose + + + + + 
Lactose + + + + + 
Mellibiose + + + + + 
Saccharose + + + + + 
Trehalose 
Inuline 
Melezitose + + + + + 
D-Raffi.nose + + + + + 
Amidon 
Gluconate 




API-SO CH kit 
Reactions for Bifidobacterium longum as listed in the ninth edition of Bergey 's 























IDENTIFICATION CHARACTERISTICS OF COMMERCIALLY 
AVAILABLE STRAINS OF Bifidobacterium longum1 
Bergey3 I II III ATCC 15707 
+ + + + + 
+ ·+ + + + 
+/- + + + + 
+ + + + + 
+ + + + + 
+/-
+ + -+ + + 
+ + + + + 
+ + + + + 
+ + + + + 
+ + + + + 
+ + + + + 
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API-50 CH kit 
Reactions for Bifidobacterium longum as listed in the ninth edition of Bergey 's 
Manual of Systemic Bacteriology. 










INFLUENCE OF 0.3% OXGALL ON GROWTH OF 
Bifidobacterium longum 
Time In Hours1 
Rep. 1 Rep. 2 Rep.3 
6.59. 5.47 4.26 
7.52 8.25 4.45 
9.48 8.48 4.45 
8.16 10.00 5.00 
4.48 6.02 4.32 
8.32 9.21 8.23 
>10.00 >10.00 >10.00 











1 Time for O.D. to increase by 0.3 units at 620nm at 37°C in MRS-TRIO broth 
supplemented with 0.3% oxgall 
2 Means with rio common superscript differ significantly 
3 Strain III was excluded .from Analysis of Variance since all three values were 
greater than 10. 00 
Analysis of Variance Table 
Source DF Sum of squares Mean square F Value 
Model1 8 57.0883048 7.1360381 5.53 
Error 12 15.4985905 1.2915492 
Total 20 72.5868952 
1 Model includes culture and replication. 
OSL < 0.05; LSD .OS = 2.02 
TableB.2 INFLUENCE OF SODIUM TAUROCHOLATE ON 
ASSIMILATION OF CHOLESTEROL 
BY B. longum S9 
Molar Cone. of µg/ml of Cholesterol Assimilated 
Sod. Taurocholate 
Rep. 1 Rep. 2 Rep.3 Mean1 
0.000 8.88 7.96 1.49 6.11a 
0.002 14.08 18.89 18.82 17.26b 
0.004 22.78 22.78 24.81 23.46c 
0.006 27.23 32.22 32.60 30.68d 
0.008 19.82 24.71 23.34 22.62e 
0.01 16.67 21.66 23.70 20.68b,c 
1 Means with no common superscript differ significantly 
Analysis of Variance Table 
Source DF Sum of squares Mean square F Value 
Model1 7 1034.421489 147.774498 19.97 
Error 10 74.015556 7.401556 
Total 17 1108.437044 
1 Model includes culture and replication 








CHOLESTEROL ASSIMILATED AND BILE SALT DECONJUGATED BY NEWLY ISOLATED 
STRAINS OF B. longum DURING 24 HOF INCUBATION AT 37°C 
µg/ml of Cholesterol Assimilated mM/ml of Bile Salt Deconjugated 
--
Rep.I Rep.2 Rep.3 Mean1 · Rep.I Rep.2 Rep.3 Mean1 
34.36 34.44 32.08 33.863 3.09 3.3S 2.26 2.903 
26.11 22.99 23.70 24.27c 3.S2 3.S2 3.18 3.41a 
30.92 26.48 23.S6 27.6Sb 3.34 2.06 2.4S 2.628 
26.67 27.78 24.07 26. l 7b.c 2.69 2.82 2.99 2.833 
1 Means with no common superscript differ significantly 
Vt 
I'-' 







Sum of squares 
17.8763167 
155.2011667 
Error 6 12.9072833 
Total 11 185.9847667 


















Total 11 2.63729167 


















CHOLESTEROL ASSIMILATED AND BILE SALT DECONJUGATION BY COMMERCIAL 
STRAINS OF B. longum DURING 24 HOF INCUBATION AT 37°C 
µg/ml of Cholesterol Assimilated mM/ml of Bile Salt Deconjugated 
Rep.I Rep.2 , Rep.3 Mean1 Rep.I Rep.2 Rep.3 Mean1 
38.33 40.00 39.27 39.20b · 3.30 3.40 2.20 2.973 
37.04 43.33 43.34 41.24a,b 3.06 2.89 2.60 2.858 
8.14 9.08 . 7.59 8.27c 1.75 0.95 1.77 1.49b 
42.04 46.48 41.66 43.398 3.40 2.84 2.70 2.988 
1 Means with no common superscript differ significantly 
u, 
""" 


































Total 11 6.4175667 


















ASSIMILATION OF CHOLESTEROL AND BILE SALT DECONJUGATION BY SELECTED 
STRAINS OF B. /ongumt DURING 18 HOF INCUBATION AT 37°C 
µg/ml of Cholesterol Assimilated mM/ml of Bile Salt Deconjugated 
Rep.I Rep.2 Rep.3 Meant Rep.I Rep.2 Rep.3 Meant 
35.37 34.44 23.33 Jl.05a 2.69 2.75 3.35 3.0oa 
41.86 30.92 29.63 34.14a 2.06 3.18 3.42 2.893 
28.52 17.41 18.15 21.36b 2.72 2.85 3.32 2.963 
25.74 22.03 19.63 22.47b 2.55 2.85 2.55 2.653 
t The best four of the eight cultures were selected based on the amount of cholesterol assimilated in previous experiments 
(Table B.3 and B.4). 
2 Means with no common superscripts differ significantly 
V, 
°' 













Total 11 634.4236250 





















Total 11 1.75429167 
OSL < 0.05; LSD .OS = 0.65 










ASSIMILATION OF CHOLESTEROL BY B. longum I 
DURING 10, 14 AND 18 H (STATIC) 
INCUBATION AT 37°C 
µg/ml of Cholesterol Assimilated 
Rep.I Rep.2 Rep.3 Mean1 
16.86 12.96 19.81 16.53b 
26.86 26.85 28.70 26.67a 
34.82 28.70 28.33 30.62& 
1 Means with no common superscripts differ significantly 
Analysis of Variance Table 
Source DF Sum of squares Mean square F Value 
Rep 2 16.9488222 8.4744111 1.01 
Culture 2 316.1430889 158.0715444 18.90 
Error 4 33.4461778 8.3615444 
Total 8 366.5380889 







ASSIMILATION OF CHOLESTEROL BY B. longum I 
AT CONTROLLED pH (6.5) AFTER 10, 14 
AND 18 HINCUBATION AT 37°C 
µg/ml of Cholesterol Assimilated 
Rep.I Rep.2 Rep.3 Mean1 
20.75 30.37 20.56 23.89c 
29.08 36.66 34.44 33.93b 
39.82 45.19 45.00 43.348 
1 Means with no common superscripts differ significantly 
Analysis of Variance Table 
Source DF Sum of squares Mean square F Value 
Rep 2 85.0950889 42.5475444 6.35 
Culture 2 567.1630889 283.5815444 42.35 
Error· 4 26.7837111 6.6959278 
Total 8 679.0418889 
OSL < 0.05; LSD .os = 5.87 
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TableB.8 CHOLESTEROL CONTENT OF B. longum I CELLS 
AND MEMBRANE DURING 18 H (pH-6.5) 
INCUBATION AT 37°C 
Fraction µg of Cholesterol /mg of Protein 











1 Means with no common superscripts differ significantly 
Analysis of Variance Table 
Source DF Sum of squares Mean square 
Rep 2 319.868433 159.934217 
Fraction 1 6200.449067 6200.449067 
Error 2 214.271233 107.135617 
Total 5 6734.588733 










ATPase ACTIVITY OF B. longum I CELL AND 
MEMBRANE DURING 18 H (pH-6.5) 
INCUBATION AT 37°C 
~p. Activity of ATPase 
Rep.I Rep.2 Rep.3 






1 Means with no common superscripts differ significantly 
Analysis of Variance Table 
Source OF Sum of squares Mean square 
Rep 2 0.00143333 0.0071667 
Fraction 1 3.33015000 3.33015000 
Error 2 0.0001000 0.0005000 
Total 5 3.33168333 















L YSIS BY SONICATION OF B. longum I GROWN IN THE PRESENCE OF 
BILE AND CHOLESTEROL 
Rep.I Rep.2 Rep.3 
DMC1/ml % Lysed DMC1/ml %Lysed DMC1/ml %Lysed 
3.6 X 109 - 1.7 X 109 - 2.} X 109 -
3.6 X 108 90.0 1.4 X 108 91.8 1.8 X 108 91.4 
2.8 X 109 - I. IX 109 - 1.6 X 109 -
2.3 X 108 91.8 I. I X 108 90.0 I. I X 108 93.0 
4.0 X }09 - 2.2 X 109 . - 2.1 X }09 -
6.6 X 108 83.5 3.5 X 108 84.1 2.6 X 108 87.6 
1 Direct Microscopic Count 







2 A= :MRS. THIO broth (0.2%); B = :MRS. THIO broth (0.2%) + sodium taurocholate (0.006 M); C = :MRS. THIO broth 
(0.2%) + sodium taurocholate (0.006 M) cholesterol-phosphatidylcholine micelles (1% - final cone.) 
3 Means with no common superscripts differ significantly 
°' N 
6~ .) 
Analysis of Variance Table - 10 min 
Source DF Sum of squares Mean square F Value 
Media 2 80.28222222 40.14111111 14.47 
Error 6 16.64000000 2.77333333 
Total 8 96.92222222 
OSL < 0.05; LSD ·05 = 3.3272 
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